Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 EUR | -0.82% | -6.74% | +13.88% |
04-15 | Claranova: new Managing Director appointed | CF |
04-15 | Correction: Claranova Appoints Successor to Outgoing CEO | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- With a P/E ratio at 11.26 for the current year and 7.33 for next year, earnings multiples are highly attractive compared with competitors.
- The company shows low valuation levels, with an enterprise value at 0.4 times its sales.
- The company has a low valuation given the cash flows generated by its activity.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.88% | 148M | C | ||
+6.97% | 3,020B | C+ | ||
+5.80% | 82.93B | B | ||
+3.72% | 76.85B | B+ | ||
-15.18% | 53.04B | B+ | ||
+32.96% | 50.15B | D+ | ||
-25.56% | 46.71B | B- | ||
+17.43% | 41.41B | D+ | ||
+59.31% | 36.1B | D+ | ||
-10.36% | 24.64B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CLA Stock
- Ratings Claranova SE